New Paradigms in Cancer Therapeutics (Z1) 2010
March 23 - 28, 2010(Ended)Fairmont Empress Hotel
Victoria, Canada
Victoria, Canada
The advent of genome-scale profiling
technologies has opened up the possibility of comprehensively
monitoring multiple layers of molecular aberrations in cancer.
Alterations in the epigenome, genome, transcriptome, proteome and
metabolome have all been observed in tumor development. A number of key
molecular pathways have been found to be altered during cancer
progression. Pivotal questions in the field include: Can these novel
pathways alone or in combination be effectively targeted in cancer? Can
we identify molecular signatures that will facilitate personalized
medicine? What are the innovative therapeutic modalities that can be
employed to target these pathways? The goal of this meeting is to
tackle promising new targets for cancer therapy. These include targets
such as recurrent gene fusions, epigenetic pathways, and metabolic
networks. We will also explore the use of molecular marker panels to
select patients for treatment. A number of approaches to therapeutic
targeting will be discussed including novel biologics and RNA
interference.Venue
Address
721 Government Street, BC.,
Victoria,
Canada
Victoria,
Canada
Prices *
520-845 US Dollar (Early registration date: January 25, 2010)
Abstract submission deadline
December 29, 2009
Organization
Concurrent events
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Mechanisms of hearing loss in prematures and fullterms with perinatal or postnatal hypoxia
- Determine the prevalence of hypermetropia among young male and female
- Health conferences
- Cancer Basic Research
- Correlation existing between the decreasing values of central corneal thickness and worsening of the field defect in primary open angle glaucoma (Health/Opthalmology)
- A Study of clinical profile and treatment outcome of DOTS regime in 250 pulmonary and extra pulmonary patients in Hamidia hospital ,Bhopal in the year 2011
